NCT06787131 2025-12-05Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy VolunteersLomond Therapeutics Holdings, Inc.Phase 1 Completed104 enrolled